Non-Comparative, Two-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab *BMS-936558) in classical Hodgkin Lymphoma (cHL) Subjects after Failure of Autologous Stem Cell Transplant (ASCT)

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
Non-Comparative, Two-Cohort, Single Arm, Open-Label, Phase 2 Study of Nivolumab *BMS-936558) in classical Hodgkin Lymphoma (cHL) Subjects after Failure of Autologous Stem Cell Transplant (ASCT)

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.